Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans

ConditionPTSD
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorThe University of Texas Health Science Center, Houston

About this trial

This study aims to explore the mechanisms of how transcranial magnetic stimulation (TMS) impacts fear circuits. The overarching objectives are to understand how varying TMS parameters affect targeted brain regions in order to optimize its impact on enhancing fear extinction memory consolidation in a population with known fear extinction deficiencies: post-traumatic stress disorder (PTSD). 250 subjects will take part in this research study across UTHealth Houston. The study will include preliminary screenings, baseline visits, and experimental visits across four days

Eligibility criteria

Qualifiers

Willing and able to provide informed consent.

Inclusion Criteria for PTSD Subjects - Diagnosis of current PTSD

Inclusion Criteria: Healthy Controls (HC) - no current psychiatric disorders ("Axis I" disorders)

Disqualifiers

Lifetime history of seizure or significant head trauma or other significant neurologic disease (e.g., tic disorder)

History of serious/significant psychiatric diagnoses ("Axis I" diagnoses)

Current significant suicidal ideation, plan or intent or suicidal behavior in past 6 months based on CSSRS and clinical judgment or Self-injurious behavior that involves suicidal intent, requires medical attention, or occurs daily

Use of neuroleptics within one year prior to study

Trial design

Treatments tested in this trial

  • Transcranial magnetic stimulation (TMS)
  • Fear Conditioning and Extinction Paradigm

Treatment groups

250 Participants
are divided into 1 treatment group

Sponsors and collaborators

The University of Texas Health Science Center, Houston

Lead sponsor

National Institute of Mental Health (NIMH)

Collaborator